JF
RVMD icon

Jump Financial’s Revolution Medicines RVMD Stock Holding History

Jump Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12M Sell
11,332
-30,998
-73% -$4.53M 0.02% 869
2026
Q1 		$4.12M Buy
+42,330
New +$4.27M 0.05% 412
2025
Q4 		– Sell
-21,495
Closed -$1M – 2237
2025
Q3 		$1M Buy
21,495
+6,237
+41% +$244K 0.01% 1019
2025
Q2 		$561K Buy
15,258
+7,137
+88% +$274K 0.01% 1200
2025
Q1 		$287K Buy
+8,121
New +$330K ﹤0.01% 1309
2023
Q4 		– Sell
-15,209
Closed -$421K – 2181
2023
Q3 		$421K Buy
+15,209
New +$451K 0.02% 1106
2023
Q1 		– Sell
-27,456
Closed -$654K – 1994
2022
Q4 		$654K Buy
+27,456
New +$584K 0.03% 668
2022
Q3 		– Sell
-63,800
Closed -$1.24M – 1910
2022
Q2 		$1.24M Sell
63,800
-4,000
-6% -$77.9K 0.05% 490
2022
Q1 		$1.73M Buy
67,800
+43,900
+184% +$955K 0.07% 325
2021
Q4 		$602K Buy
+23,900
New +$674K 0.04% 573
2021
Q1 		– Sell
-14,016
Closed -$555K – 1233
2020
Q4 		$555K Buy
+14,016
New +$554K 0.09% 347

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jump Financial's RVMD Position: Q2 2026 in Review

Jump Financial reduced its Revolution Medicines (RVMD) stake by 73% in Q2 2026, selling an estimated $4.53M and leaving 11,332 shares worth $2.12M. The position accounts for 0.02% of the portfolio, ranked #869.

Jump Financial first reported a position in RVMD in Q4 2020 and has held it in 11 quarters since. The position peaked at $4.12M in Q1 2026. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Jump Financial held 11,332 shares of Revolution Medicines worth $2.12M as of Q2 2026.
  • Jump Financial sold 30,998 Revolution Medicines shares in Q2 2026, an estimated $4.53M.
  • Revolution Medicines made up 0.02% of Jump Financial's portfolio in Q2 2026, its #869 holding.
  • Jump Financial first reported a position in Revolution Medicines in Q4 2020 and has held it in 11 quarters since.
  • Jump Financial's Revolution Medicines position peaked at $4.12M in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.